spacer
home > ebr > summer 2002 > genetic aspects of mental retardation
PUBLICATIONS
European Biopharmaceutical Review

Genetic Aspects of Mental Retardation

Mental retardation is the most common plague of mankind. It is a lifelong disease characterised by impairment of cognitive and adaptive skills. More than any other type of disorder, mental retardation has a predominating effect on the life of the patient and the relatives. Thus, mental retardation lays an unrivalled burden on society. Estimates regarding its frequency vary, but it is generally quoted that it affects one to three per cent of the population (1).The causes of the developmental delay are extremely heterogeneous, and although half of the mental retardation cases are of unknown etiology today, it has been estimated that half of all cases are due to environmental factors and the remaining half to genetic factors. Environmental factors include exposure to toxic substances (such as alcohol or drugs), radiation, infection and so on during pregnancy.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Frank Kooy chairs the Mental Retardation Research Group within the Department of Medical Genetics at the University of Antwerp, Belgium.

He is a graduate of the University of Utrecht in the Netherlands and received a PhD in Molecular Parasitology from the same university. A national fund for scientific research postdoctoral fellowship at the University of Groningen in the Netherlands brought him into the field of human genetics.

spacer
Dr Frank Kooy
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MedPharm accelerates strategy to broaden service offering into commercial manufacturing

MedPharm Ltd, a leading contract provider of topical and transdermal product design and development services, has announced two new appointments to its Board to support plans to grow its commercial manufacturing services.
More info >>

White Papers

Smaller, Smarter, Electronic, Connected: The Next Generation of Drug-Delivery Devices

Phillips-Medisize

An exciting trend in drug delivery is underway: the movement toward smaller, smarter, wirelessly connected electronic devices that allow patient-administered therapy. Inspired by the technological advancements driving the consumer electronics market, new methods for drug delivery show great promise for all stakeholders. Patients wishing to claim more autonomy over their drug regimens, caregivers and medical professionals wanting to more closely monitor drug compliance, health insurance organizations looking to keep costs down, and developers of pharmaceutical products interested in conducting better managed clinical trials can all benefit from these novel, next-generation technologies.
More info >>

 
Industry Events

CPhI & P-MEC China

18-20 June 2019, SNIEC, Shanghai, China

CPhI & P-MEC China 2019 is your gateway to successfully grow your business at the 2nd largest pharma market in the world. Whether you are looking for sourcing new business or getting the latest market insight, this is your one-stop shop pharmaceutical platform in Asia.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement